# FDA Inspection 1260248 - Cardiac Insight - February 07, 2025

Source: https://www.keypedia.com/records/fda_inspections/cardiac-insight/45c90ed4-5de8-4b72-a2f5-691634c418e9
Source feed: FDA_Inspections

> FDA Inspection 1260248 for Cardiac Insight on February 07, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1260248
- Company Name: Cardiac Insight
- Inspection Date: 2025-02-07
- Classification: No Action Indicated (NAI)
- Project Area: Postmarket Assurance: Medical Devices
- Product Type: Medical Devices & Rad Health
- Office Name: Seattle District Office

## Related Documents

- [FDA Inspection 1260248 - 2025-02-07](https://www.keypedia.com/records/fda_inspections/cardiac-insight/90b8837a-3b0d-4d97-a88c-7a7581e41834)
- [FDA Inspection 1000914 - 2017-02-10](https://www.keypedia.com/records/fda_inspections/cardiac-insight/05992d3f-fe94-41db-b4a5-5865b95b52ec)
- [FDA Inspection 1000914 - 2017-02-10](https://www.keypedia.com/records/fda_inspections/cardiac-insight/f73e9932-228d-4f27-83e2-98b0ff33dbda)
- [FDA Inspection 878017 - 2014-05-09](https://www.keypedia.com/records/fda_inspections/cardiac-insight/3364d3e9-e571-4c22-8e56-2872900879bb)

Company: https://www.keypedia.com/companies/cardiac-insight/86852d41-0a30-46c3-b661-ca06fb7b9bb3

Office: https://www.keypedia.com/offices/seattle-district-office/9305837f-0738-4075-b444-a55e7a2b8913